COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral vector development and ...
Toronto, Ontario--(Newsfile Corp. - May 17, 2021) - Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTC: MMJFF) ("Matica" or the "Company") announces today that further to our news releases of May 3, ...
Parks will spearhead development and execution of Matica Bio’s commercial strategic initiatives as EVP of Commercial Operations Sugrue to advance business development goals, partnerships as VP of ...
Expects to file its 2020 Annual Financial Statements on or before May 31, 2021 Toronto, Ontario--(Newsfile Corp. - April 15, 2021) - Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) ...
COLLEGE STATION, Texas, Sept. 15, 2025 /PRNewswire/ -- Matica Biotechnology, Inc. (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral vector ...
A lack of global capacity to produce cell and gene therapies has been exacerbated by an even more pressing need: to develop and manufacture coronavirus vaccines. So it appears the timing is right for ...
CHA Biotech subsidiary Matica Biolabs signed a contract to manufacture medical developer TiCARos' new CAR-T cancer therapy drugs for clinical trials, the companies said Wednesday. Under the two ...
Matica designs, manufactures and distributes cost-efficient, flexible solutions for industrial card personalization and card mailing systems for banking, government, access control, ID and ...
Matica Fintec S.p.A., a world-leading manufacturer and provider of technology solutions for Financial and Government Institutions, has announced the acquisition of Panini S.p.A., a global leader in ...
Hosted on MSN
Matica Fintec Announces Early Bond Loan Repayment
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Matica Fintec SpA ( (IT:MFT)) has ...
Matica Biotechnology, a CDMO specializing in viral vector manufacturing for cell and gene therapies, reports that it signed a strategic commercial manufacturing agreement with a clinical-stage biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback